Oxbow Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.8M | Sell |
44,224
-724
| -2% | -$169K | 0.92% | 23 |
|
|
2025
Q4 | $9.3M | Sell |
44,948
-351
| -0.8% | -$69.4K | 0.82% | 27 |
|
|
2025
Q3 | $8.4M | Buy |
45,299
+636
| +1% | +$109K | 0.78% | 24 |
|
|
2025
Q2 | $6.82M | Buy |
44,663
+1,258
| +3% | +$193K | 0.75% | 31 |
|
|
2025
Q1 | $7.2M | Buy |
43,405
+1,869
| +4% | +$292K | 0.76% | 32 |
|
|
2024
Q4 | $6.01M | Buy |
41,536
+213
| +0.5% | +$33K | 0.71% | 36 |
|
|
2024
Q3 | $6.7M | Buy |
41,323
+1,474
| +4% | +$235K | 0.66% | 36 |
|
|
2024
Q2 | $5.82M | Buy |
39,849
+359
| +0.9% | +$53.4K | 0.68% | 38 |
|
|
2024
Q1 | $6.25M | Buy |
39,490
+1,600
| +4% | +$255K | 0.86% | 35 |
|
|
2023
Q4 | $5.94M | Buy |
37,890
+29,278
| +340% | +$4.49M | 0.9% | 29 |
|
|
2023
Q3 | $1.34M | Sell |
8,612
-8,314
| -49% | -$1.37M | 0.21% | 65 |
|
|
2023
Q2 | $2.8M | Sell |
16,926
-130
| -0.8% | -$21K | 0.44% | 45 |
|
|
2023
Q1 | $2.64M | Sell |
17,056
-310
| -2% | -$50.1K | 0.47% | 43 |
|
|
2022
Q4 | $3.07M | Buy |
17,366
+2
| +0% | +$345 | 0.58% | 39 |
|
|
2022
Q3 | $2.84M | Buy |
17,364
+548
| +3% | +$92.7K | 0.45% | 47 |
|
|
2022
Q2 | $2.98M | Sell |
16,816
-99
| -0.6% | -$17.6K | 0.42% | 49 |
|
|
2022
Q1 | $3M | Sell |
16,915
-112
| -0.7% | -$19.1K | 0.3% | 61 |
|
|
2021
Q4 | $2.91M | Hold |
17,027
| – | – | 0.28% | 70 |
|
|
2021
Q3 | $2.75M | Sell |
17,027
-85,567
| -83% | -$14.6M | 0.28% | 76 |
|
|
2021
Q2 | $16.9M | Buy |
102,594
+6,758
| +7% | +$1.12M | 1.76% | 13 |
|
|
2021
Q1 | $15.8M | Buy |
95,836
+1,577
| +2% | +$255K | 1.92% | 10 |
|
|
2020
Q4 | $14.8M | Buy |
94,259
+29,320
| +45% | +$4.33M | 1.9% | 9 |
|
|
2020
Q3 | $9.67M | Sell |
64,939
-8,658
| -12% | -$1.28M | 1.23% | 20 |
|
|
2020
Q2 | $10.3M | Buy |
73,597
+10,775
| +17% | +$1.57M | 1.51% | 13 |
|
|
2020
Q1 | $8.24M | Sell |
62,822
-3,802
| -6% | -$539K | 1.39% | 21 |
|
|
2019
Q4 | $9.72M | Sell |
66,624
-325
| -0.5% | -$44.1K | 1.12% | 17 |
|
|
2019
Q3 | $8.66M | Buy |
66,949
+34,313
| +105% | +$4.52M | 1.15% | 16 |
|
|
2019
Q2 | $4.55M | Buy |
32,636
+735
| +2% | +$102K | 0.55% | 48 |
|
|
2019
Q1 | $4.46M | Buy |
31,901
+110
| +0.3% | +$14.7K | 0.54% | 42 |
|
|
2018
Q4 | $4.1M | Sell |
31,791
-241
| -0.8% | -$33.6K | 0.55% | 45 |
|
|
2018
Q3 | $4.43M | Buy |
32,032
+484
| +2% | +$64.3K | 0.53% | 55 |
|
|
2018
Q2 | $3.83M | Sell |
31,548
-246
| -0.8% | -$30.7K | 0.49% | 60 |
|
|
2018
Q1 | $4.07M | Buy |
31,794
+983
| +3% | +$133K | 0.83% | 38 |
|
|
2017
Q4 | $4.3M | Buy |
30,811
+77
| +0.3% | +$10.7K | 0.81% | 34 |
|
|
2017
Q3 | $4M | Sell |
30,734
-5,381
| -15% | -$713K | 0.76% | 36 |
|
|
2017
Q2 | $4.78M | Sell |
36,115
-267
| -0.7% | -$34.1K | 0.84% | 33 |
|
|
2017
Q1 | $4.53M | Sell |
36,382
-921
| -2% | -$110K | 0.74% | 43 |
|
|
2016
Q4 | $4.3M | Buy |
37,303
+335
| +0.9% | +$38.7K | 0.54% | 51 |
|
|
2016
Q3 | $4.37M | Sell |
36,968
-806
| -2% | -$97.8K | 0.6% | 47 |
|
|
2016
Q2 | $4.58M | Sell |
37,774
-1,026
| -3% | -$117K | 0.66% | 44 |
|
|
2016
Q1 | $4.2M | Sell |
38,800
-1,586
| -4% | -$164K | 0.59% | 48 |
|
|
2015
Q4 | $4.15M | Buy |
40,386
+5,459
| +16% | +$549K | 0.52% | 61 |
|
|
2015
Q3 | $3.26M | Buy |
34,927
+7,446
| +27% | +$720K | 0.54% | 58 |
|
|
2015
Q2 | $2.68M | Buy |
27,481
+1,870
| +7% | +$187K | 0.35% | 84 |
|
|
2015
Q1 | $2.58M | Sell |
25,611
-145
| -0.6% | -$14.7K | 0.38% | 65 |
|
|
2014
Q4 | $2.69M | Sell |
25,756
-1,066
| -4% | -$112K | 0.38% | 70 |
|
|
2014
Q3 | $2.86M | Buy |
26,822
+684
| +3% | +$70.9K | 0.4% | 62 |
|
|
2014
Q2 | $2.73M | Sell |
26,138
-1,730
| -6% | -$175K | 0.36% | 68 |
|
|
2014
Q1 | $2.74M | Hold |
27,868
| – | – | 0.41% | 62 |
|
|
2013
Q4 | $2.55M | Sell |
27,868
-130
| -0.5% | -$12K | 0.36% | 72 |
|
|
2013
Q3 | $2.43M | Sell |
27,998
-185
| -0.7% | -$16.6K | 0.39% | 66 |
|
|
2013
Q2 | $2.42M | Buy |
+28,183
| New | +$2.39M | 0.42% | 55 |
|
Other funds holding JNJ
VCM
VPM
Oxbow Advisors's JNJ Position: Q1 2026 in Review
Oxbow Advisors reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, selling an estimated $169K and leaving 44,224 shares worth $10.8M. The position accounts for 0.92% of the portfolio, ranked #23.
Oxbow Advisors first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.9M in Q2 2021. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Oxbow Advisors held 44,224 shares of Johnson & Johnson worth $10.8M as of Q1 2026.
- Oxbow Advisors sold 724 Johnson & Johnson shares in Q1 2026, an estimated $169K.
- Johnson & Johnson made up 0.92% of Oxbow Advisors's portfolio in Q1 2026, its #23 holding.
- Oxbow Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- Oxbow Advisors's Johnson & Johnson position peaked at $16.9M in Q2 2021.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Oxbow Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.